<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - MHRA Authorizes Pfizer, BioNTech COVID-19 Vaccine
Image Overlay - MHRA Authorizes Pfizer, BioNTech COVID-19 Vaccine

MHRA Authorizes Pfizer, BioNTech COVID-19 Vaccine

December 8, 2020

MHRA Authorizes Pfizer, BioNTech COVID-19 Vaccine

The U.K.'s Medicines & Healthcare Products Regulatory Agency (MHRA) granted a temporary authorization for emergency use to Pfizer and BioNTech for their COVID-19 mRNA vaccine BNT162b2 . This is the first Emergency Use Authorization following a worldwide phase III trial of a vaccine to help fight the pandemic. Like the global population, Yourway has closely followed COVID-19 vaccine trials and is excited about the beginnings of a wider rollout of the vaccine.

 Back to Index
Media

Upcoming Events

GCSG 2024 US Conference

April 21-24, 2024
Naples, Florida

Precision in Clinical Trials Summit (Boston)

May 6-7, 2024
Hilton Boston Park Plaza

Media

Articles

Regulatory barriers in cross-border European pharmaceutical transport

Open chat
Come chat with us!
Hello! How can I help you?